Broken bricks and cracked mortar - epidermal diseases resulting from genetic abnormalities

Drug Discovery Today: Disease Mechanisms

Volumn 5, Issue 1, 2008, Pages

  Lane, E Birgitte ^a,b   McLean, W H Irwin ^c  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b INSTITUTE OF MEDICAL BIOLOGY   (Singapore)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSKELETON PROTEIN; DERMATOLOGICAL AGENT; FILAGGRIN; GAMMA GLUTAMYLTRANSFERASE; GAP JUNCTION PROTEIN; KERATIN; LAMININ; LAMININ BETA 3; POLYMER; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 1; RETINOID DERIVATIVE; RETROVIRUS VECTOR; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ATOPIC DERMATITIS; BIOTECHNOLOGY; BLISTER; CELL DIFFERENTIATION; CELL MATURATION; CLINICAL TRIAL; DISEASE SEVERITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG RESEARCH; DRUG SAFETY; DRUG TOLERABILITY; DYSKERATOSIS; EPIDERMIS; EPIDERMIS CELL; EPIDERMOLYSIS BULLOSA; EPITHELIUM CELL; GENE MUTATION; GENE SILENCING; GENETIC DISORDER; GENETIC SUSCEPTIBILITY; GENETIC TRAIT; HUMAN; KERATINOCYTE; MOLECULAR BIOLOGY; MULTIGENE FAMILY; MUTATIONAL ANALYSIS; NONHUMAN; NONVIRAL GENE THERAPY; PHENOTYPE; PROTEIN TARGETING; REVIEW; RNA INTERFERENCE; SKIN CELL; SKIN DISEASE; SKIN MANIFESTATION; SKIN STRUCTURE; SKIN TOXICITY; VIRAL GENE DELIVERY SYSTEM;

EID: 67349156412     PISSN: 17406765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddmec.2008.09.001     Document Type: Review

References (54)

1. Lane E.B. Keratins. In: Royce P.M., and Steinmann B. (Eds). Connective Tissue and its Heritable Disorders. Molecular, Genetic and Medical Aspects (1993), Wiley-Liss Inc. 237-247
2. Kim S., et al. A keratin cytoskeletal protein regulates protein synthesis and epithelial cell growth. Nature 441 (2006) 362-365
3. Candi E., et al. The cornified envelope: a model of cell death in the skin. Nat. Rev. Mol. Cell Biol. 6 (2005) 328-340
4. Omary M.B., et al. Intermediate filament proteins and their associated diseases. N. Engl. J. Med. 351 (2004) 2087-2100
5. Bonifas J.M., et al. Epidermolysis bullosa simplex: evidence in two families for keratin gene abnormalities. Science 254 (1991) 1202-1205
6. Coulombe P.A., et al. Point mutations in human keratin 14 genes of epidermolysis bullosa simplex patients: genetic and functional analysis. Cell 66 (1991) 1301-1311
7. Lane E.B., et al. A mutation in the conserved helix termination peptide of keratin 5 in hereditary skin blistering. Nature 356 (1992) 244-246
8. Irvine A.D., and McLean W.H.I. Human keratin diseases: the increasing spectrum of disease and subtlety of the phenotype-genotype correlation. Br. J. Dermatol. 140 (1999) 815-828
9. Szeverenyi I., et al. The Human Intermediate Filament Database: comprehensive information on a gene family involved in many human diseases. Hum. Mutat. 29 (2008) 351-360
10. Lane E.B., and McLean W.H.I. Keratins and skin disorders. J. Pathol. 204 (2004) 355-366
11. Smith T.A., et al. Sequence comparisons of intermediate filament chains: evidence of a unique functional/structural role for coiled-coil segment 1A and linker L1. J. Struct. Biol. 137 (2002) 128-145
12. Herrmann H., and Foisner R. Intermediate filaments: novel assembly models and exciting new functions for nuclear lamins. Cell Mol. Life Sci. 60 (2003) 1607-1612
13. Moll R., et al. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 31 (1982) 11-24
14. Lane E.B. Monoclonal antibodies provide specific intramolecular markers for the study of epithelial tonofilament organization. J. Cell Biol. 92 (1982) 665-673
15. Broers J.L., et al. Immunocytochemical detection of human lung cancer heterogeneity using antibodies to epithelial, neuronal, and neuroendocrine antigens. Cancer Res. 47 (1987) 3225-3234
16. McLean W.H.I., et al. Keratin 16 and keratin 17 mutations cause pachyonychia congenita. Nat. Genet. 9 (1995) 273-278
17. Bowden P.E., et al. Mutation of a type II keratin gene (K6a) in pachyonychia congenita. Nat. Genet. 10 (1995) 363-365
18. Smith F.J.D., et al. A mutation in human keratin K6b produces a phenocopy of the K17 disorder pachyonychia congenita type 2. Hum. Mol. Genet. 7 (1998) 1143-1148
19. Rugg E.L., et al. A mutation in the mucosal keratin K4 is associated with oral white sponge nevus. Nat. Genet. 11 (1995) 450-452
20. Richard G., et al. Keratin-13 point mutation underlies the hereditary mucosal epithelial disorder white sponge nevus. Nat. Genet. 11 (1995) 453-455
21. Irvine A.D., et al. Mutations in cornea-specific keratins K3 or K12 cause Meesmann's corneal dystrophy. Nat. Genet. 16 (1997) 184-187
22. Rothnagel J.A., et al. Mutations in the rod domain of keratin 2e in patients with ichthyosis bullosa of Siemens. Nat. Genet. 7 (1994) 485-490
23. McLean W.H.I., et al. Ichthyosis bullosa of Siemens - a disease involving keratin 2e. J. Invest. Dermatol. 103 (1994) 277-281
24. Smith F.J.D., et al. Plectin deficiency results in muscular dystrophy with epidermolysis bullosa. Nat. Genet. 13 (1996) 450-457
25. McLean W.H.I., et al. Loss of plectin causes epidermolysis-bullosa with muscular-dystrophy - cDNA cloning and genomic organization. Genes Dev. 10 (1996) 1724-1735
26. McGrath J.A., et al. Mutations in the plakophilin 1 gene can result in ectodermal dysplasia/skin fragility syndrome. Nat. Genet. 17 (1997) 240-244
27. Armstrong D.K., et al. Haploinsufficiency of desmoplakin causes a striate subtype of palmoplantar keratoderma. Hum. Mol. Genet. 8 (1999) 143-148
28. Rickman L., et al. N-terminal deletion in a desmosomal cadherin causes the autosomal dominant skin disease striate palmoplantar keratoderma. Hum. Mol. Genet. 8 (1999) 971-976
29. Bonifas J.M., et al. Cloning of a cDNA for steroid sulfatase: frequent occurrence of gene deletions in patients with recessive X chromosome-linked ichthyosis. Proc. Natl. Acad. Sci. U. S. A. 84 (1987) 9248-9251
30. Jensen T.G., et al. Correction of steroid sulfatase deficiency by gene transfer into basal cells of tissue-cultured epidermis from patients with recessive X-linked ichthyosis. Exp. Cell Res. 209 (1993) 392-397
31. Freiberg R.A., et al. A model of corrective gene transfer in X-linked ichthyosis. Hum. Mol. Genet. 6 (1997) 927-933
32. Choate K.A., et al. Corrective gene transfer in the human skin disorder lamellar ichthyosis. Nat. Med. 2 (1996) 1263-1267
33. Varki R., et al. Epidermolysis bullosa. II. Type VII collagen mutations and phenotype-genotype correlations in the dystrophic subtypes. J. Med. Genet. 44 (2007) 181-192
34. Varki R., et al. Epidermolysis bullosa. I. Molecular genetics of the junctional and hemidesmosomal variants. J. Med. Genet. 43 (2006) 641-652
35. Featherstone C., and Uitto J. Ex vivo gene therapy cures a blistering skin disease. Trends Mol. Med. 13 (2007) 219-222
36. Vailly J., et al. Corrective gene transfer of keratinocytes from patients with junctional epidermolysis bullosa restores assembly of hemidesmosomes in reconstructed epithelia. Gene Ther. 5 (1998) 1322-1332
37. Mavilio F., et al. Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells. Nat. Med. 12 (2006) 1397-1402
38. Pike-Overzet K., et al. New insights and unresolved issues regarding insertional mutagenesis in X-linked SCID gene therapy. Mol. Ther. 15 (2007) 1910-1916
39. Kaspar R.L. Challenges in developing therapies for rare diseases including pachyonychia congenita. J. Invest. Dermatol. Symp. Proc. 10 (2005) 62-66
40. Rana T.M. Illuminating the silence: understanding the structure and function of small RNAs. Nat. Rev. Mol. Cell Biol. 8 (2007) 23-36
41. Smith F.J.D., et al. The genetic basis of pachyonychia congenita. J. Invest. Dermatol. Symp. Proc. 10 (2005) 21-30
42. Smith F.J.D., et al. Development of therapeutic siRNAs for pachyonychia congenita. J. Invest. Dermatol. 128 (2008) 50-58
43. Schweizer J., et al. New consensus nomenclature for mammalian keratins. J. Cell Biol. 174 (2006) 169-174
44. Wong P., et al. Introducing a null mutation in the mouse K6alpha and K6beta genes reveals their essential structural role in the oral mucosa. J. Cell Biol. 150 (2000) 921-928
45. Wojcik S.M., et al. Delayed wound healing in keratin 6a knockout mice. Mol. Cell Biol. 20 (2000) 5248-5255
46. Hickerson R.P., et al. Single-nucleotide-specific siRNA targeting in a dominant-negative skin model. J. Invest. Dermatol. 128 (2008) 594-605
47. Kerns M.L., et al. Reprogramming of keratin biosynthesis by sulforaphane restores skin integrity in epidermolysis bullosa simplex. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 14460-14465
48. Presland R.B., and Dale B.A. Epithelial structural proteins of the skin and oral cavity: function in health and disease. Crit. Rev. Oral Biol. Med. 11 (2000) 383-408
49. Spergel J.M., and Paller A.S. Atopic dermatitis and the atopic march. J. Allergy Clin. Immunol. 112 6 Suppl. (2003) S118-127
50. Smith F.J.D., et al. Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris. Nat. Genet. 38 (2006) 337-342
51. Palmer C.N.A., et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat. Genet. 38 (2006) 441-446
52. Sandilands A., et al. Comprehensive analysis of the gene encoding filaggrin uncovers prevalent and rare mutations in ichthyosis vulgaris and atopic eczema. Nat. Genet. 39 (2007) 650-654
53. Brown S.J., et al. Filaggrin null mutations and childhood atopic eczema: a population-based case-control study. J. Allergy Clin. Immunol. 121 (2008) 940-946
54. Sandilands A., et al. Filaggrin's fuller figure: a glimpse into the genetic architecture of atopic dermatitis. J. Invest. Dermatol. 127 (2007) 1282-1284